Mathieu Molimard
Mathieu Molimard
Verifierad e-postadress på - Startsida
Citeras av
Citeras av
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib
D Marin, A Bazeos, FX Mahon, L Eliasson, D Milojkovic, M Bua, ...
Journal of clinical oncology 28 (14), 2381, 2010
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia
S Picard, K Titier, G Etienne, E Teilhet, D Ducint, MA Bernard, R Lassalle, ...
Blood 109 (8), 3496-3499, 2007
Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care
M Molimard, C Raherison, S Lignot, F Depont, A Abouelfath, N Moore
Journal of aerosol medicine 16 (3), 249-254, 2003
Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy
AR Ibrahim, L Eliasson, JF Apperley, D Milojkovic, M Bua, R Szydlo, ...
Blood, The Journal of the American Society of Hematology 117 (14), 3733-3736, 2011
The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
M Cazzola, M Molimard
Pulmonary pharmacology & therapeutics 23 (4), 257-267, 2010
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
S Dulucq, S Bouchet, B Turcq, E Lippert, G Etienne, J Reiffers, ...
Blood 112 (5), 2024-2027, 2008
MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation
J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ...
Allergy 70 (11), 1372-1392, 2015
Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study
N Lechevallier‐Michel, M Molimard, JF Dartigues, C Fabrigoule, ...
British journal of clinical pharmacology 59 (2), 143-151, 2005
Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans
M Molimard, B Diquet, MS Benedetti
Fundamental & clinical pharmacology 18 (4), 399-411, 2004
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
J Bousquet, A Addis, I Adcock, I Agache, A Agusti, A Alonso, ...
European Respiratory Journal 44 (2), 304-323, 2014
Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients
M Molimard, C Raherison, S Lignot, A Balestra, S Lamarque, A Chartier, ...
European Respiratory Journal 49 (2), 2017
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
J Bousquet, HJ Schünemann, PW Hellings, S Arnavielhe, C Bachert, ...
Journal of Allergy and Clinical Immunology 138 (2), 367-374. e2, 2016
Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS
S Bouchet, E Chauzit, D Ducint, N Castaing, M Canal-Raffin, N Moore, ...
Clinica Chimica Acta 412 (11-12), 1060-1067, 2011
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
C Guignabert, C Phan, A Seferian, A Huertas, L Tu, R Thuillet, C Sattler, ...
The Journal of clinical investigation 126 (9), 3207-3218, 2016
High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active …
K Titier, N Castaing, E Scotto-Gomez, F Pehourcq, N Moore, M Molimard
Therapeutic drug monitoring 25 (5), 581-587, 2003
Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma
AB Suttle, HA Ball, M Molimard, TE Hutson, C Carpenter, D Rajagopalan, ...
British journal of cancer 111 (10), 1909-1916, 2014
Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi
E Naline, A Trifilieff, RA Fairhurst, C Advenier, M Molimard
European Respiratory Journal 29 (3), 575-581, 2007
Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry
K Titier, S Picard, D Ducint, E Teilhet, N Moore, P Berthaud, FX Mahon, ...
Therapeutic drug monitoring 27 (5), 634-640, 2005
Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia
JE Cortes, MJ Egorin, F Guilhot, M Molimard, FX Mahon
Leukemia 23 (9), 1537-1544, 2009
Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France
M Molimard, F de Blay, A Didier, V Le Gros
Respiratory medicine 102 (1), 71-76, 2008
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20